Low Dose Ionizing Radiation Using CT Scans as a Potential Therapy for Alzheimer's Dementia: A Pilot Study
NCT03597360 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4
Last updated 2022-03-02
Summary
The goal of this project is to determine whether low doses of ionizing radiation (LDIR) from repeat CT scanning improves function, cognition and/or behavior in severe AD.
Conditions
- Dementia Alzheimers
Interventions
- RADIATION
-
CT scan
Participants will receive the first LDIR treatment in one session on the same day, i.e., two CT scans of the brain that delivers a total X-ray dose (CTDIvol)10 of about 80 mGy. Participants will then be transported back to Baycrest Health Sciences. Participants will receive another LDIR treatment, i.e. a single CT scan of the brain (40 mGy), 2 weeks after the first session. They will receive a third LDIR treatment, i.e., a single CT scan of the brain (40 mGy), 2 weeks after the second session. Date, time and X-ray dose will be recorded for each participant and sent to their family physician for entry into in their health record.
Sponsors & Collaborators
-
Baycrest
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 70 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-08
- Primary Completion
- 2020-04-01
- Completion
- 2020-04-01
Countries
- Canada
Study Locations
More Related Trials
-
TNF-Alpha Inhibition for Treatment of Alzheimer's Disease
NCT00203359 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers
NCT01153607 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease
NCT03901105 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355
NCT03802162 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility Study of Transcranial Ultrasound Stimulation on Alzheimer's Disease Patients
NCT03896698 ·Status: UNKNOWN ·Phase: NA
-
Deep Brain Stimulation for Alzheimer's Disease
NCT03959124 ·Status: UNKNOWN ·Phase: NA
-
Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG
NCT04735536 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
NCT02791191 ·Status: TERMINATED ·Phase: PHASE2
-
Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease
NCT05122598 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease
NCT01482845 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease
NCT01195389 ·Status: UNKNOWN ·Phase: NA
-
Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects
NCT06151808 ·Status: COMPLETED ·Phase: NA
-
Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study
NCT02420756 ·Status: COMPLETED
-
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
NCT03703856 ·Status: COMPLETED ·Phase: PHASE4
-
Positron Emission Tomography Study Using 2-[18F]-F-A85380 to Determine α4β2 Neuronal Nicotinic Receptor Occupancy of AZD3480 After Oral Administration to Healthy Male Subjects
NCT00686413 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
NCT00605059 ·Status: TERMINATED ·Phase: PHASE1
-
Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's
NCT02769000 ·Status: TERMINATED ·Phase: NA
-
TNF-Alpha Inhibition for Treatment of Alzheimer's Disease
NCT00203320 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Scientific Validity of Low-dose Whole Brain Radiotherapy in Alzheimer's Disease.
NCT04203121 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers
NCT01035164 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC
NCT00544453 ·Status: TERMINATED ·Phase: PHASE1
-
Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease
NCT03903211 ·Status: COMPLETED ·Phase: PHASE2
-
Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease
NCT02035982 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease
NCT03522129 ·Status: COMPLETED ·Phase: PHASE1
-
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
NCT02912936 ·Status: COMPLETED ·Phase: NA